Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-26 @ 10:57 AM
Ignite Modification Date:
2025-12-26 @ 10:57 AM
NCT ID:
NCT02043808
Eligibility Criteria:
Inclusion criteria:
* Patients must be continuously enrolled in a health plan during the pre-index period;
* Patients must have at least one inpatient, or one physician office visit, emergency room visit with a diagnosis of AF (ICD-9-CM diagnosis code: 427.31in any position) on the index date or during the pre-index period;
* Patients must have a prescription for dabigatran or warfarin (this first prescription will be the index date);
* Patients must be treatment naive from all OAC use prior to first dabigatran or warfarin prescription;
* Aged 18-89 on the index date;
Exclusion criteria:
* Patients with valvular procedures related to the baseline AF diagnosis will be excluded;
* Patients with transient causes of AF such as hyperthyroidism, any cardiac surgery, pericarditis, mycoarditis, pulmonary embolism within 3 months prior to their first diagnosis of AF;
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT02043808
Study Brief:
Protocol Section:
NCT02043808